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Abstract
Fluorescent butanetriol-containing phospholipid analogs were synthesized by replacing the glycerol moiety in
1-hexadecanoyl-2-[6-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) aminohexanoyl]-sn-glycero-3-phosphocholine, -phosphoetha-
nolamine, -phosphoserine and 1-hexadecanoyl-2-[12-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminododecanoyl]-sn-glycero-3-
phosphocholine, -phosphoethanolamine, -phosphoserine by the 1,3,4-butanetriol residue, and their out-to-in translocation in
the human erythrocyte membrane studied by ‘back exchanging’ the outer surface-incorporated phospholipids using bovine
serum albumin. The results of these studies indicate that the replacement of the glycerol moiety by the 1,3,4-butanetriol
residue in aminophospholipids does not effect their out-to-in translocation in the human erythrocyte membrane.
Furthermore, since earlier study by Arora and Gupta (Biochim. Biophys. Acta 1324 (1997) 47^60) has shown that the
conformation of the 1,3,4-butanetriol phospholipids possess the backbone conformation similar to that of glycero-
phospholipids, it is suggested that besides the normal phospholipid polar head-group, a normal phospholipid interface
conformation may also be required for the aminophospholipid^translocase interactions. ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Transbilayer movement of membrane phospholip-
ids is a fundamental process of membrane biogen-
esis and cell growth [1,2]. It is now well established
that these movements, at least in the plasma mem-
brane, are mediated by the membrane-bound pro-
teins [2^4]. While some of these proteins translocate
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Abbreviations: TLC, thin-layer chromatography; FAB, fast atom bombardment; EDTA, N,N,NP,NP-ethylenediaminetetraacetic acid;
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; NBD, 7-nitrobenz-2-oxa-1,3-diazol-4-yl ; HPLC, high-
pressure liquid chromatography; NMR, nuclear magnetic resonance; s, singlet ; d, doublet; b, broad; m, multiplet ; BSA, bovine serum
albumin; C6-NBD-PC, -PE, -PS, 1-hexadecanoyl-2-[6-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) aminohexanoyl]-sn-glycero-3-phosphocholine,
-phosphoethanolamine, -phosphoserine; C12-NBD-PC, -PE, -PS, 1-hexadecanoyl-2-[12-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminodode-
canoyl]-sn-glycero-3-phosphocholine, -phosphoethanolamine, -phosphoserine; C6-NBD-bPC, -bPE, -bPS, 1-hexadecanoyloxy-3-[6-N-(7-
nitrobenz-2-oxa-1,3-diazol-4-yl)aminohexanoyloxy]-(3R)-but-4-yl-phosphocholine, -phosphoethanolamine, -phosphoserine; C12-NBD-
bPC, -bPE, -bPS, 1-hexadecanoyloxy-3-[12-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminododecanoyloxy]-(3R)-but-4-yl-phosphocholine,
-phosphoethanolamine, -phosphoserine; PBS, phosphate-bu¡ered saline (10 mM phosphate, 140 mM NaCl, pH 7.4); HS bu¡er,
HEPES-saline bu¡er (20 mM HEPES, 137 mM NaCl, 3 mM KCl, 10 mM glucose, pH 7.4)
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only a speci¢c class of phospholipids [5^7], non-spe-
ci¢c translocating proteins have also been reported
[5,8].
Out-to-in translocation of aminophospholipids in
human erythrocytes is mediated by an ATPase-like
protein [9^11]. Several studies have shown that this
protein translocates PS at a faster rate than PE, but
it does not translocate PC under identical conditions
[2,3]. Furthermore, it has been reported that this
aminophospholipid translocase recognizes not only
the amino group on the lipid polar moiety, but
also the glycerol and the ester bonds [12]. To further
investigate the role of glycerol backbone in amino-
phospholipids^translocase interactions, we replaced
the glycerol residue by the 1,3,4-butanetriol moiety
in diacylglycerophospholipids and then studied
the out-to-in translocation of modi¢ed phospho-
lipids (Fig. 1) in intact erythrocytes. The results
of these studies clearly demonstrate that inser-
tion of one methylene residue between the car-
bons that carry the two acyl chains in aminophos-
pholipids (PE and PS) does not signi¢cantly e¡ect
their out-to-in movements in the erythrocyte mem-
brane.
Fig. 1. Molecular structures of NBD-labeled PC, PE and PS analogs wherein the glycerol moiety has been replaced by 1,3,4-butane-
triol residue.
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2. Materials and methods
2.1. Materials
All the reagents and solvents used in the study were
of the highest purity available. L-Serine, ethanol-
amine, calcium chloride, HEPES, sodium acetate,
n-octyl-L-D-glycopyranoside, Triton X-100, Tris-
HCl, BSA and EDTA were purchased from Sig-
ma. CF-11 was bought from Whatman, Germany
and silica gel (60^120 mesh) was from Sisco, Bom-
bay.
2.2. General methods
Purity of various reaction intermediates was
checked by TLC on silica gel G-60 plates. Homoge-
neity of phospholipids was established by both TLC
and HPLC. TLC plates were developed in chloro-
form/methanol/water (65:25:4, v/v/v) mixture and
the phospholipid spots visualized by staining the plate
with iodine vapor followed by Molybdenum blue
spray [13]. Two-dimensional TLC was performed on
precoated Merck aluminium-backed silica gel G-60
plates. The plates were developed in chloroform/
methanol/ammonia (65:25:4, v/v/v) in one dimension
followed by chloroform/methanol/acetone/acetic acid/
water (40:8:16:9:4, v/v/v/v) in a direction at right
angles to the ¢rst dimension. The spots were visual-
ized as described above. HPLC was performed using
Waters HPLC pump (Model 510) along with Waters
R401 di¡erential refractometer or Waters £uores-
cence detector (Model 420-AC) interfaced with
Waters System Interface Module. Chromatograms
were analyzed by using baseline 810 software. Ana-
lytical HPLC was performed on an Altex Ultrasphere
C18 reverse-phase column (4.6U250 mm, particle size
5 Wm) using methanol/chloroform/water (87:13:6, v/
v/v) containing 176 mM choline chloride, at a £ow
rate of 1.0 ml/min, as the elution system, whereas
preparative HPLC was carried out on an LKB
TSK-ODS-120T semiprep column (7.8U300 mm,
particle size 10 Wm) using methanol/chloroform/water
(90:10:4, v/v/v) at a £ow rate of 2 ml/min as the
eluent.
Phospholipids were puri¢ed by preparative TLC,
Sephadex LH-20 column (2.5U100 cm) chromatogra-
phy, and preparative HPLC. The Sephadex LH-20
column was eluted with chloroform/methanol (1:1,
v/v) mixture at a £ow rate of about 60 ml/h. All the
phospholipids thus-puri¢ed exhibited single spot on
TLC and single peak on analytical HPLC, and were
characterized by NMR and mass spectrometry anal-
yses. 1H-NMR spectra were recorded on a Bruker
ACP 300 FT-NMR spectrometer, and the chemical
shifts have been expressed in parts per million
down-¢eld from tetramethylsilane. Positive ion FAB
mass spectrometry was performed on a Jeol JMS-SX




ammonium)ethyl] phosphate was prepared as de-
scribed earlier [14]. It was treated with Naja naja
snake venom (Sigma) and the resulting 1-hexadeca-
noyloxy-3-hydroxy-(3R)-but-4-yl-[2-(trimethylammo-
nium)ethyl] phosphate was isolated in pure form by
following the published procedure [15]. Reaction of
this lysolipid with 6-N-(7-nitrobenz-2-oxa-1,3-diazol-
4-yl) aminohexanoic acid and 12-N-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl) aminododecanoic acid in the
presence of 1,1P-carbonyldiimidazole [16] a¡orded
C6-NBD-bPC (Fig. 1) and C12-NBD-bPC (Fig. 1) re-
spectively. Similarly, C6-NBD-PC and C12-NBD-PC
were prepared using 1-hexadecanoyl-sn-glycero-3-
phosphocholine as the starting material, which in
turn was prepared as described earlier [17]. C6-
NBD-PC: FAB mass 772 (MH) ; 1H-NMR
(CDCl3/CD3OD) N 8.49 (d, J = 9 Hz, 1H), 6.23 (d,
J = 9 Hz, 1H), 5.28^5.21 (m, 1H), 4.37^4.29 (b, 2H),
4.17^4.08 (m, 2H), 4.03^3.97 (m, 2H), 3.85^3.75 (b,
2H), 3.30 (s, 9H). C12-NBD-PC: FAB mass 856
(MH) ; 1H-NMR (CDCl3/CD3OH) N 8.50 (d, J = 9
Hz, 1H), 6.19 (d, J = 9 Hz, 1H), 5.27^5.20 (m, 1H),
4.30^4.20 (b, 2H), 4.18^4.10 (m, 2H), 4.02^3.97 (m,
2H), 3.63^3.56 (b, 2H), 3.22 (s, 9H). C6-NBD-bPC:
FAB mass 786 (MH) ; 1H-NMR (CDCl3/CD3OD) N
8.44 (d, J = 9 Hz, 1H), 6.14 (d, J = 9 Hz, 1H), 5.08^
5.01 (m, 1H), 4.27^4.21 (b, 2H), 4.14^4.04 (b, 2H),
4.02^3.99 (m, 2H), 3.58^3.49 (b, 2H), 3.14 (s, 9H),
2.03^1.82 (m, 2H). C12-NBD-bPC: FAB mass 870
(MH) ; 1H-NMR (CDCl3/CD3OD) N 8.43 (d, J = 9
Hz, 1H), 6.14 (d, J = 9 Hz, 1H), 5.06^5.00 (m, 1H),
4.29^4.21 (b, 2H), 4.16^4.05 (b, 2H), 4.03^4.01 (m,
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2H), 3.56^3.46 (b, 2H), 3.14 (s, 9H), 2.04^1.82 (m,
2H).
C6-NBD-PS, C6-NBD-bPS, C6-NBD-PE, C6-
NBD-bPE, C12-NBD-PS, C12-NBD-bPS C12-NBD-
PE and C12-NBD-bPE (Fig. 1) were prepared by
transesteri¢cation of their corresponding NBD-PC
and NBD-bPC analogs using published procedure
[18]. C6-NBD-PS: FAB mass 774 (MH) ; 1H-NMR
(CDCl3/CD3OD) N 8.47 (d, J = 8.7 Hz, 1H), 6.16 (d,
J = 8.7 Hz, 1H), 5.38^5.26 (m, 1H), 4.36^4.24 (b, 2H),
4.20^4.13 (b, 2H), 4.04^3.95 (m, 2H), 3.65^3.58 (b,
1H). C6-NBD-bPS: FAB mass 788 (MH) ; 1H-
NMR (CDCl3/CD3OD) N 8.44 (d, J = 9 Hz, 1H),
6.11 (d, J = 9 Hz, 1H), 5.32^5.24 (m, 1H), 4.37^4.23
(b, 2H), 4.20^4.12 (b, 2H), 4.03^3.97 (m, 2H), 3.65^
3.59 (b, 1H), 2.33^2.10 (m, 2H). C12-NBD-PS: FAB
mass 858 (MH) ; 1H-NMR (CDCl3/CD3OD) N 8.48
(d, J = 8.7 Hz, 1H), 6.21 (d, J = 8.7 Hz, 1H), 5.22^5.16
(m, 1H), 4.34^4.26 (b, 2H), 4.20^4.08 (b, 2H), 4.07^
4.01 (m, 2H), 3.62^3.53 (b, 1H). C12-NBD-bPS: FAB
mass 872 (MH) ; 1H-NMR (CDCl3/CD3OD) N 8.37
(d, J = 9 Hz, 1H), 6.09 (d, J = 9 Hz, 1H), 5.07^5.01 (m,
1H), 4.29^4.21 (b, 2H), 4.14^4.04 (b, 2H), 4.03^3.97
(m, 2H), 3.59^3.46 (b, 1H), 1.98^1.82 (m, 2H). C6-
NBD-PE: FAB mass 730 (MH) ; 1H-NMR
(CDCl3/CD3OD) N 8.43 (d, J = 8.7 Hz, 1H), 6.13 (d,
J = 8.7 Hz, 1H), 5.22^5.15 (m, 1H), 4.35^4.24 (b, 2H),
4.22^4.10 (b, 2H), 4.05^3.98 (m, 2H), 3.61^3.47 (b,
2H). C6-NBD-bPE: FAB mass 744 (MH) ; 1H-
NMR (CDCl3/CD3OD) N 8.46 (d, J = 9 Hz, 1H),
6.16 (d, J = 9 Hz, 1H), 5.29^5.21 (m, 1H), 4.38^4.26
(b, 2H), 4.24^4.13 (b, 2H), 4.06^3.99 (m, 2H), 3.64^
3.51 (b, 2H), 2.31^2.09 (m, 2H). C12-NBD-PE: FAB
mass 814 (MH) ; 1H-NMR (CDCl3/CD3OD) N 8.44
(d, J = 8.7 Hz, 1H), 6.12 (d, J = 8.7 Hz, 1H), 5.16^5.07
(m, 1H), 4.38^4.25 (b, 2H), 4.20^4.11 (b, 2H), 4.10^
4.03 (m, 2H), 3.67^3.49 (b, 2H). C12-NBD-bPE:
FAB mass 828 (MH) ; 1H-NMR (CDCl3/CD3OD)
N 8.45 (d, J = 9 Hz, 1H), 6.13 (d, J = 9 Hz, 1H),
5.13^5.06 (m, 1H), 4.36^4.24 (b, 2H), 4.19^4.09
(b, 2H), 4.06^3.99 (m, 2H), 3.67^3.49 (b, 2H), 2.02^
1.81 (m, 2H).
2.4. Erythrocytes
Human erythrocytes from freshly drawn healthy
human donor blood in acid citrate-dextrose were
washed three times with PBS. The bu¡y coat was
removed and the erythrocytes were resuspended in
PBS. The suspension was passed through a CF-11
column to remove any remnants of leucocytes. In all
the experiments, the fresh human erythrocytes from
single donor were used.
2.5. ATP depletion of erythrocytes
Erythrocytes were starved of energy by incubating
them in a bu¡er composed of 50 mM Tris-HCl, 5 mM
KCl, 2 mM CaCl2, 2 mM MgCl2, 90 mM NaCl, 0.2
mg/ml streptomycin and 200 IU/ml penicillin (pH 7.4)
at 37‡C [11] under nitrogen atmosphere. Aliquots
were taken at the required intervals. ATP levels in
fresh and starved erythrocytes were determined using
the hexokinase/glucose-6-phosphate dehydrogenase
assay of Lamprecht and Trautschold [29].
2.6. Translocation of lipids from outer-to-inner lea£et
Erythrocytes (2U108 cells) were suspended in 1 ml
of ice cold HS bu¡er. NBD-labeled lipid analog in
ethanol (1 Wg/10 Wl) was then added to the erythrocyte
suspension (2U108 cells/ml) in HS bu¡er, mixed rap-
idly and incubated at 0‡C for 20 min. After incuba-
tion, the erythrocytes were washed two times with ice
cold HS bu¡er, and then resuspended in 1 ml of the
same bu¡er. It was incubated at 37‡C and aliquots
(100 Wl) were drawn at the required intervals. To
each aliquot was then added 1 ml of HS bu¡er con-
taining 1% BSA. The mixture was incubated at 0‡C
for 10 min to remove the lipid located in the outer
surface of the cells (back exchange). Cells incubated
with the C12 analogs were processed similarly except
that for back exchange cells were incubated with 10%
BSA for 20 min at 0‡C. The cells were pelleted and
washed 6 or 7 times with 1 ml each time of HS bu¡er
to remove traces of BSA. The cell pellet was solubi-
lized in 500 Wl of 1% Triton X-100, and the £uores-
cence intensity was measured. The fraction of lipid
translocated from outer-to-inner lea£et was deter-
mined by comparing the amounts of lipid remaining
in the cells before and after back exchange to BSA.
Steady state £uorescence of NBD labeled lipids
was measured on a Perkin Elmer LS 5000 spectro-
£uorometer at an emission wavelength of 521 nm (ex-
citation, 470 nm) at room temperature using 10 nm
slit widths.
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3. Results
Out-to-in movements of phospholipids was moni-
tored by incorporating £uorescent phospholipids in
the human erythrocytes, and then back-exchanging
the thus-incorporated lipids to BSA at di¡erent
time intervals [19]. The £uorescent phospholipids
were synthesized by acylating the corresponding ly-
solipids with NBD-containing C6 or C12 fatty acids,
as reported earlier [16,18]. All the phospholipids
(Fig. 1) were puri¢ed to homogeneity and character-
ized by NMR and mass spectrometry, as described in
Section 2.
Fig. 2 shows that both C6-NBD-PC and C12-
NBD-PC failed to translocate from the outer-to-in-
ner lea£et of erythrocyte membrane bilayer, which is
quite in agreement with the earlier reports [19,20].
Like PC, the corresponding butanetriol analogs,
viz. C6-NBD-bPC and C12-NBD-bPC, also failed to
translocate across the membrane bilayer. Consistent
with the earlier observations [19,21,22], C6-NBD-PE
very poorly migrated to the inner monolayer, but its
corresponding C12 derivative translocated at least up
to 75% to the inner lea£et of the erythrocyte mem-
brane bilayer (Fig. 3). Almost identical results were
observed by employing the corresponding butanetriol
analogs in place of C6-NBD-PE and C12-NBD-PE
(Fig. 3). Similarly, no signi¢cant di¡erences were ob-
Fig. 2. Translocation of PC analogs from outer to the inner
membrane lea£et of human erythrocytes at 37‡C. (A) Solid
circles, C6-NBD-PC; open circles, C6-NBD-bPC. (B) Solid
squares, C12-NBD-PC; open squares, C12-NBD-bPC. Values
shown are the mean of 3^5 observations þ S.D.
Fig. 3. Translocation of PE analogs from outer to the inner
membrane lea£et of human erythrocytes at 37‡C. (A) Solid
circles, C6-NBD-PE; open circles, C6-NBD-bPE. (B) Solid
squares, C12-NBD-PE; open squares, C12-NBD-bPE. Values
shown are the mean of 5^7 observations þ S.D.
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served between the PS (C6-NBD-PS and C12-NBD-
PS) and the corresponding butanetriol analogs (C6-
NBD-bPS and C12-NBD-bPS) in the extent of their
out-to-in movements (Fig. 4).
To examine whether the out-to-in translocation of
butanetriol-containing phospholipids, like the glyc-
erophospholipids [9^11], is in£uenced by the cellular
ATP levels, we depleted the human erythrocytes of
ATP and then studied the out-to-in movement of
C12-NBD-PS and C12-NBD-bPS. Cellular ATP was
depleted by incubating the erythrocytes under starv-
ing conditions, as described earlier [11]. The ATP
levels dropped to about 25% in 6 h and to less
than 10% in 18 h. Fig. 5 shows that the extent of
out-to-in translocation of both C12-NBD-PS and
C12-NBD-bPS decreased with a decrease in the cel-
lular ATP content, and was almost abolished by
starving the cells of energy for 18 h.
4. Discussion
Present study demonstrates that replacement of
the glycerol backbone by the 1,3,4-butanetriol resi-
due in PC, PE and PS does not e¡ect their out-to-in
movements in the erythrocyte membrane. This is in
contrast to the earlier study which concluded that
besides the polar head-group, glycerol residue and
the ester groups are also required for translocation
of PE and PS to the inner monolayer [12]. Since this
conclusion was based on the very poor translocation
of the ceramide-containing PS derivatives in the er-
ythrocyte membrane, we suggest that this behavior
may well be attributed to a tighter association of
these derivatives with the translocase because of the
H-bonding character of the ceramide residue [23].
It would seem that the formation of a productive
complex between the translocase and aminophospho-
lipids besides requiring the polar head-group also
requires the interface conformation typical to the
glycerophospholipids [24,25]. This is based on our
earlier study which showed that the conformational
preference around the butanetriol C2^C3 bond in
butanetriol-containing phospholipids is almost iden-
tical to that observed with the glycerol C1^C2 bond
in phosphatidylcholines [14]. Also it is consistent
with the previous study of Martin and Pagano [26]
wherein they showed that the D-isomers of NBD-PE
and NBD-PS are not transported by the aminophos-
pholipid translocase. Furthermore, it may ¢nd sup-
port from the work of Morrot et al. [12], who in spite
of the substitution of the glycerol moiety in PS by
the ceramide residue, could still observe detectable
translocation of the PS analogs, as contrast to sphin-
gomyelins, in the erythrocyte membrane. Further-
more, we suggest that the C1 ester moiety may not
play a crucial role in the glycerophospholipid^trans-
locase interactions, since the preferred conformation
of the butanetriol-containing phospholipids is such
wherein the additional methylene, rather than the
C1 methylene, serves as the proximal beginning of
the primary acyl chain [14], which should result in
Fig. 4. Translocation of PS analogs from outer to the inner
membrane lea£et of human erythrocytes at 37‡C. (A) Solid
circles, C6-NBD-PS; open circles, C6-NBD-bPS. (B) Solid
squares, C12-NBD-PS; open squares, C12-NBD-bPS. Values
shown are the mean of 5^7 observations þ S.D.
BBAMEM 77408 3-8-98
V. Puri, C.M. Gupta / Biochimica et Biophysica Acta 1373 (1998) 59^6664
displacement of the C1 ester by one additional meth-
ylene in the phospholipid structure [24,25].
It is interesting to observe that the out-to-in trans-
location of the aminophospholipids that carry C6
acyl chain at the C2 position of the glycerol moiety
in glycerophospholipids or at the C3 position of the
butanetriol residue in butanetriol-containing phos-
pholipids was signi¢cantly smaller than that of the
corresponding C12 fatty acyl chain-containing phos-
pholipids, which is quite in agreement with the ear-
lier ¢ndings [19,21]. This result may suitably be ex-
plained in the light of the earlier observations of
Chattopadhyay and London [27]. These authors
have shown that the NBD group attached to a £ex-
ible acyl chain in phospholipids tend to loop back to
the surface due to its polar nature. This ‘looping
back’ may cause greater distortion of the phospho-
lipid conformation in case of C6-NBD-PE or C6-
NBD-PS due to very short acyl chain length, as com-
pared to C12-NBD-PE or C12-NBD-PS, which in
turn could lead to poor interactions between the ami-
nophospholipid and translocase.
Earlier studies have shown that the erythrocyte
membrane aminophospholipid translocase speci¢-
Fig. 5. E¡ect of ATP depletion on translocation of C12-NBD-bPS from outer to the inner membrane lea£et of human erythrocytes at
37‡C. Fresh erythrocytes were divided into two parts. One part was incubated, for varying time intervals, in a bu¡er composed of 50
mM Tris-HCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 90 mM NaCl, 0.2 mg/ml streptomycin and 200 IU/ml penicillin (pH 7.4) at
37‡C under nitrogen and the other part was incubated under the same conditions in HS bu¡er. The cells were washed and then sus-
pended in HS bu¡er (without glucose) and out-to-in translocation of C12-NBD-PS and C12-NBD-bPS was measured. Solid circles,
out-to-in translocation of C12-NBD-PS in erythrocytes incubated under normal conditions; solid squares, out-to-in translocation of
C12-NBD-PS in erythrocytes incubated under starving conditions; open circles, out-to-in translocation of C12-NBD-bPS in erythro-
cytes incubated under normal conditions; open squares, out-to-in translocation of C12-NBD-bPS in erythrocytes incubated under
starving conditions. (A) 0 h incubation; (B) 6 h incubation; (C) 12 h incubation; (D) 18 h incubation. Values shown are the mean of
3^5 observations þ S.D.
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cally recognizes the phospholipid polar head group
[12]. This behavior of the protein is quite similar to
that of the other phospholipid-speci¢c transfer pro-
teins [28]. In case of PC-speci¢c exchange protein, it
has been suggested that this protein transfers only
those PC derivatives which have normal polar
head-group con¢guration [28]. It is therefore likely
that the aminophospholipid translocase, besides rec-
ognizing the phospholipid backbone conformation,
also recognizes the speci¢c polar head-group con¢g-
uration. This is well supported by our earlier ¢ndings
[14] that butanetriol-containing phospholipids be-
sides possessing the backbone conformation similar
to that of glycerophospholipids also possess similar
polar head-group con¢guration.
In conclusion, this study demonstrates that re-
placement of the glycerol residue in PE and PS by
the 1,3,4-butanetriol moiety does not e¡ect the ATP-
dependent out-to-in translocation of these phospho-
lipids in the human erythrocyte membrane. Further-
more, it suggests that this translocation, besides re-
quiring the speci¢c phospholipid polar head-group,
may also require speci¢c phospholipid backbone
conformation.
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